• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Equal survival rates for first, second, and third episodes of Pneumocystis carinii pneumonia in patients with acquired immunodeficiency syndrome.

作者信息

Dohn M N, Baughman R P, Vigdorth E M, Frame D L

机构信息

Department of Internal Medicine, University of Cincinnati Medical Center, OH.

出版信息

Arch Intern Med. 1992 Dec;152(12):2465-70. doi: 10.1001/archinte.152.12.2465.

DOI:10.1001/archinte.152.12.2465
PMID:1456858
Abstract

BACKGROUND

Second and subsequent episodes of acute Pneumocystis carinii pneumonia (PCP) are reported to have a worse prognosis than initial episodes in patients with the acquired immunodeficiency syndrome. We tested the hypothesis that survival rates of first, second, and subsequent episodes of acute PCP in patients with the acquired immunodeficiency syndrome are equal.

METHODS

Analysis of the outcomes in prospective series of patients with the acquired immunodeficiency syndrome treated for acute PCP over 5 years.

RESULTS

Survival rates of 222 PCP occurrences by episode number were: first, 86%; second, 84%; third, 88%; and fourth, 67%. Survival rates for the first, second, and third episodes were not significantly different. Second and third episodes had a larger proportion of patients with mild disease than initial episodes.

CONCLUSIONS

Survival rates for first, second, and third episodes of PCP in patients with the acquired immunodeficiency syndrome are not different. In contrast to earlier articles, treatment for second and third episodes of acute PCP may be as successful as in initial episodes.

摘要

相似文献

1
Equal survival rates for first, second, and third episodes of Pneumocystis carinii pneumonia in patients with acquired immunodeficiency syndrome.
Arch Intern Med. 1992 Dec;152(12):2465-70. doi: 10.1001/archinte.152.12.2465.
2
Pneumocystis prophylaxis and survival in patients with advanced human immunodeficiency virus infection treated with zidovudine. The Zidovudine Epidemiology Group.接受齐多夫定治疗的晚期人类免疫缺陷病毒感染患者的肺孢子菌预防与生存情况。齐多夫定流行病学研究组。
Arch Intern Med. 1992 Oct;152(10):2009-13.
3
Prognostic factors of early fatal outcome and long-term survival in patients with Pneumocystis carinii pneumonia and acquired immunodeficiency syndrome.卡氏肺孢子虫肺炎合并获得性免疫缺陷综合征患者早期致命结局及长期生存的预后因素
Eur J Epidemiol. 1993 Mar;9(2):183-9. doi: 10.1007/BF00158789.
4
Pneumocystis carinii pneumonia in patients in the developing world who have acquired immunodeficiency syndrome.发展中国家患有获得性免疫缺陷综合征患者的卡氏肺孢子虫肺炎。
Clin Infect Dis. 2003 Jan 1;36(1):70-8. doi: 10.1086/344951. Epub 2002 Dec 16.
5
[Improved prognosis of first episode HIV associated Pneumocystis carinii pneumonia without preventive treatment: etiology and sequelae].[未经预防性治疗的初发人类免疫缺陷病毒相关卡氏肺孢子虫肺炎的预后改善:病因及后遗症]
Pneumologie. 1996 Jul;50(7):455-61.
6
Effects of mutations in Pneumocystis carinii dihydropteroate synthase gene on outcome of AIDS-associated P. carinii pneumonia.卡氏肺孢子虫二氢蝶酸合酶基因突变对艾滋病相关卡氏肺孢子虫肺炎结局的影响。
Lancet. 1999 Oct 16;354(9187):1347-51. doi: 10.1016/S0140-6736(99)03320-6.
7
Mechanical ventilation for Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome. Is the prognosis really improved?获得性免疫缺陷综合征患者卡氏肺孢子虫肺炎的机械通气治疗。预后真的得到改善了吗?
Chest. 1993 Sep;104(3):756-62. doi: 10.1378/chest.104.3.756.
8
Changes in survival after acquired immunodeficiency syndrome (AIDS): 1984-1991.获得性免疫缺陷综合征(艾滋病)患者生存率的变化:1984 - 1991年
Am J Epidemiol. 1993 Dec 1;138(11):952-64. doi: 10.1093/oxfordjournals.aje.a116815.
9
Corticosteroids improve survival of children with AIDS and Pneumocystis carinii pneumonia.皮质类固醇可提高患艾滋病和卡氏肺孢子虫肺炎儿童的生存率。
Am J Dis Child. 1993 Jan;147(1):30-4. doi: 10.1001/archpedi.1993.02160250032012.
10
Changes in survival over time after a first episode of Pneumocystis carinii pneumonia for European patients with acquired immunodeficiency syndrome. Multicentre Study Group on AIDS in Europe.欧洲获得性免疫缺陷综合征患者首次卡氏肺孢子虫肺炎发作后的生存时间变化。欧洲艾滋病多中心研究小组。
Arch Intern Med. 1995 Apr 24;155(8):822-8.

引用本文的文献

1
Structure and inhibition of human diamine oxidase.人二胺氧化酶的结构与抑制作用
Biochemistry. 2009 Oct 20;48(41):9810-22. doi: 10.1021/bi9014192.
2
Early predictors of mortality from Pneumocystis jirovecii pneumonia in HIV-infected patients: 1985-2006.1985 - 2006年HIV感染患者中耶氏肺孢子菌肺炎死亡的早期预测因素
Clin Infect Dis. 2008 Feb 15;46(4):625-33. doi: 10.1086/526778.
3
Pneumocystis carinii pneumonia in adolescents.
Paediatr Drugs. 2000 Mar-Apr;2(2):133-8. doi: 10.2165/00148581-200002020-00006.
4
The management of Pneumocystis carinii pneumonia.卡氏肺孢子虫肺炎的管理
Br J Clin Pharmacol. 1999 Jun;47(6):605-9. doi: 10.1046/j.1365-2125.1999.00966.x.
5
Prophylaxis against opportunistic infections in patients infected with the human immunodeficiency virus.对感染人类免疫缺陷病毒患者的机会性感染的预防
West J Med. 1996 Jul-Aug;165(1-2):67-73.
6
Prognostic factors influencing the outcome in pneumocystis carinii pneumonia in patients with AIDS.影响艾滋病患者卡氏肺孢子虫肺炎预后的因素
Thorax. 1995 Jun;50(6):668-71. doi: 10.1136/thx.50.6.668.